Our Training Programs
Our training programs serve a growing need for the training of skilled therapists and mental health professionals who seek to attain advanced skills in the field for future Health Canada-approved psychedelic-assisted psychotherapy practice. We use the term “psychedelic” to refer to the classic and newer psychedelics (Psilocybin, MDMA, LSD, Iboga, Ayahuasca, Ketamine etc.). Participants are health professionals in licensed mental health and medical professions who are seeking to integrate psychedelic medicine and psychedelic-assisted psychotherapy into their clinical practices.
The training program itself is rooted in contemporary medical and mental health research, and also provides the historical foundation from which psychedelic medicines developed. Varied approaches to psychedelic-assisted therapy are presented, including trans-personal psychology, consciousness studies and psychoanalysis, while maintaining a focus on contemporary research and therapy innovation




View our course programs
-
Introduction to
Psychedelic-assisted Therapy -
Psilocybin-assisted
Therapy Program
Introduction to Psychedelic-assisted Therapy
15 lessons
CE Credits
Includes
- Full sessions
- Lesson resources
- 4 hours of interactive Q&A with instructors
- Access to ATMA's network
Introduction
Our PAA co-sponsored Introduction to Psychedelic-assisted Therapy Program begins with re-defining the psychiatric model from one of “chemical imbalance” to one rooted in the mind-body-spirit dynamic that psychedelic therapeutic treatment can bring to the client.
It will include didactic material providing a basic understanding of the various psychedelic and entheogenic medicines currently in use, including Psilocybin, MDMA, LSD, Iboga, Ayahuasca, Ketamine, and other lesser known psychedelics.
Benefits
Expand your practice
Gain the
right tools
Support your patients
Grow your network
Lesson Plan
Live Q&A
- History of Psychedelics
- Ethics in Psychedelic Therapy
- Wellness Enhancement
- Palliative Care
- Iboga in Addictions and Other Therapy
- Mushrooms/Psilocybin
- MDMA
- Ketamine: Insights from the Emergency Department
- Manual of Psychedelic Guides
- A Relational Model of Psychedelic Integration
- Self-Care for the Psychedelic Guide
Student Testimonial
ATMA's Introduction to Psychedelic-Assisted Therapy was truly an invaluable course. There was so much helpful information. Thank you so much for opening this training up to various helping professionals.
ATMA Academy Alumni
FAQ
Who is this current training course intended for?
What if I am a healthcare professional but not a registered therapist?
What will this training course equip me to do?
Coming out of this course, you will have a basic understanding of:
- The various psychedelic medicines in use today;
- How to best set up a session with a client in psychedelic therapy;
- Some of the legal and ethical issues that need to be considered when using psychedelic psychotherapy;
- A sense of how and for which applications these medicines work; and
- A clear path on what is required in order for you to introduce this work to your practice when these medicines become legalized.
Are there any in-person training sessions available?
Can I view the training sessions after the sessions are complete?
Is there a refund if my situation changes?
Join today!
Psilocybin-assisted Therapy Training Program
We believe it is critical and beneficial, from both the client and health care provider perspective, for therapists to gain direct knowledge and an experiential understanding of the effects of psilocybin as psychedelic medicine in order to increase efficacy in the provision of psychedelic-assisted psychotherapies. Our program will provide legal psilocybin experiential and guidance training under a clinical trial umbrella as approved by Health Canada.
*The Introduction to Psychedelic-assisted Therapy is a required course.
prerequisite
100 hours of training
40 hours trial participation
Includes
- Workshops
- Online learning
- Coaching
- Psilocybin based clinical research participation
- Access to ATMA’s manual to psilocybin-assisted therapy
- Access to ATMA's network
Introduction
This training program will prepare licensed healthcare
professionals to provide psilocybin-assisted therapy to
their clients. Participants will also be offered the
opportunity to enroll in a Phase II Clinical Trial, as and
when approved by Health Canada. The primary
objective of this trial is to document the efficacy
profile of psilocybin in treating general anxiety of
mental healthcare professionals resulting from COVID19. A secondary exploratory objective is to have
participants complete self-assessments on the
psychological outcome of psilocybin. Details on the
trial will be made available when appropriate.
Enrollment begins August 2022
Benefits
Participate in
clinical trials
Hands-on experience
Competitive
advantage
Grow your network
Lesson Plan
Psilocybin Clinical Trials
Through Health Canada-approved clinical trials, ATMA will work to demonstrate the effectiveness of psilocybin in treating
a variety of mental health indications. From basic safety to efficacy trials, ATMA will answer critical questions
surrounding the use of psilocybin in a clinical setting.
As the COVID-19 pandemic wanes, ATMA’s first priority will be trials focusing on front-line workers who have been
dealing with work-related stress associated with the psychological fallout of the last two years; it will include physicians,
counselors, psychologists, and psychiatrists. Participation in these trials will also provide these mental healthcare
providers the unique opportunity to experience the effects of psilocybin treatment in a safe clinical setting. This first-hand
experience will be useful to therapists for when psilocybin is eventually legalized for psychotherapy.
Get notified about the latest updates
FAQ
Do I get to experience psilocybin therapy as a participant?
How does the experiential portion of the class work?
What kinds of therapy will this program allow me to offer?
Is there a refund if my situation changes and I can't make the cohort I signed up for?
The ATMA Network
Available with Premium. Recognizing the limited time and resources at your disposal, we provide a turn-key solution to help you incorporate Psychedelic-assisted Therapy in your practice effortlessly. Health professionals who achieve competency in offering this therapeutic intervention will be able to adopt the treatment without any disruptions to current services they provide.
The TNS will allow Psychologists, accredited and certified Counselors and other mental health professionals across Canada to seamlessly integrate Psychedelic-assisted Therapy into clinics and independent practices with the confidence that it is done at a high-level of professionalism and integrity.
Clinical Trials
First-hand experience and therapist participation in an experiential Practicum Pilot Program
Connect
Collaboration, networking and knowledge sharing amongst peers
Events
Be the first to know about upcoming events near you or online
Updates
Free updates on the platform
Lessons
Didactic training, experiential practicums and viable adoption of Psychedelic-assisted Therapy
Referrals
An intuitive platform that serves both those seeking treatment and Therapy Practitioners wishing to expand